Drug intelligence / Profile preview

Metabolife Ephedra-Free

Development stage
Unknown
Lead developer
Metabolife
Modality
Small Molecules
Administration
Oral
01

Overview

Metabolife Ephedra-Free is a multicomponent herbal dietary supplement marketed as an aid for weight loss. It was developed as a reformulation of the original Metabolife 356, which contained ephedra (ephedrine), after ephedra was banned in the United States due to safety concerns. The "Ephedra-Free" version does not contain ephedrine but instead includes other herbal stimulants and ingredients commonly found in weight-loss supplements, such as guarana (a source of caffeine) and possibly bitter orange extract (Citrus aurantium), which contains synephrine—a compound with stimulant properties similar to those of ephedrine. The exact ingredient list may vary by batch or manufacturer, but these are typical components. Mechanistically, the supplement acts primarily through central nervous system stimulation via caffeine and/or synephrine, increasing metabolic rate and potentially promoting weight loss. However, clinical studies have shown that while single doses do not significantly affect blood pressure in healthy young adults, there can be increases in systemic vascular resistance index (SVRI). Prolonged use or use among individuals with pre-existing cardiovascular conditions may pose health risks similar to those seen with earlier ephedra-containing products[3][5][7].

Brand names
Metabolife Ephedra-Free
Other names
Metabolife Ephedra-Free
02

Targets

ADRB1 (β1)ADOR (Adenosine receptors)

Beyond the preview

Go deeper on Metabolife Ephedra-Free.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Metabolife Ephedra-Free.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call